1. Transcranial direct current stimulation in patients with obsessive compulsive disorder: A randomized controlled trial
- Author
-
Mohamed Saoud, Jerome Brunelin, Marine Mondino, Rémy Bation, Florent Le Camus, Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital neurologique et neurochirurgical Pierre Wertheimer [CHU - HCL], Hospices Civils de Lyon (HCL), Université de Lyon, CCSD, Accord Elsevier, Centre de recherche en neurosciences de Lyon (CRNL), and Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Adult ,Male ,Acute effects ,Obsessive-Compulsive Disorder ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Prefrontal Cortex ,Transcranial Direct Current Stimulation ,law.invention ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Neuroimaging ,Randomized controlled trial ,Obsessive compulsive ,law ,Neuromodulation ,medicine ,Humans ,In patient ,Transcranial direct-current stimulation ,business.industry ,Middle Aged ,Frontal Lobe ,030227 psychiatry ,3. Good health ,[SDV] Life Sciences [q-bio] ,Psychiatry and Mental health ,Treatment Outcome ,medicine.anatomical_structure ,Anesthesia ,Female ,Orbitofrontal cortex ,business ,030217 neurology & neurosurgery - Abstract
Background: Obsessive-compulsive disorder (OCD) is a severe mental disorder with poor response to the available treatments. Neuroimaging studies have identified dysfunctions within the orbito-fronto-striato-pallido-thalamic network in patients with OCD. Here, we assessed the efficacy and safety of transcranial direct current stimulation (tDCS) applied with the cathode over the orbitofrontal cortex (OFC) and the anode over the right cerebellum to decrease OCD symptoms in patients with treatment-resistant OCD. Methods: In a randomized sham-controlled double-blind study, 21 patients with OCD were assigned to receive ten 20-min sessions (two sessions per day) of either active (2 mA) or sham tDCS. The clinical symptoms were measured using the Yale-Brown Obsessive and Compulsive Scale (YBOCS). Acute effects on the symptoms were measured from baseline to immediately after the 10 tDCS sessions. Long-lasting effects were measured 1 and 3 months after the 10th tDCS session. Results: Compared with the sham tDCS, active tDCS significantly decreased OCD symptoms immediately after the 10th tDCS session (F(1,19) = 5.26, p = 0.03). However, no significant differences were observed between the active and sham groups in terms of changes in YBOCS score or the number of responders one and 3 months after tDCS. Conclusion: Despite significant acute effects, tDCS with the cathode placed over the left OFC and the anode placed over the right cerebellum was not significantly effective in inducing a long-lasting reduction of symptoms in patients with treatment-resistant OCD.
- Published
- 2019